N-hydroxy-4-[(6-nitro-1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]benzamide
C15H11N3O7S — CID 122186716
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-hydroxy-4-[(6-nitro-1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]benzamide
N-hydroxy-4-[(6-nitro-1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]benzamide (PubChem CID 122186716) has the molecular formula C15H11N3O7S and a molecular weight of 377.33 g/mol. Its IUPAC name is N-hydroxy-4-[(6-nitro-1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]benzamide.
Molecular Properties
| Compound Name | N-hydroxy-4-[(6-nitro-1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]benzamide |
|---|---|
| PubChem CID | 122186716 |
| Molecular Formula | C15H11N3O7S |
| Molecular Weight | 377.33 g/mol |
| Exact Mass | 377.03 |
| IUPAC Name | N-hydroxy-4-[(6-nitro-1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]benzamide |
| SMILES | O=C(NO)c1ccc(CN2C(=O)c3ccc([N+](=O)[O-])cc3S2(=O)=O)cc1 |
| InChI | InChI=1S/C15H11N3O7S/c19-14(16-21)10-3-1-9(2-4-10)8-17-15(20)12-6-5-11(18(22)23)7-13(12)26(17,24)25/h1-7,21H,8H2,(H,16,19) |
| InChIKey | HGBJXMADCVCXHN-UHFFFAOYSA-N |
| XLogP | 1.06 |
| TPSA | 146.92 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 377.33 |
| LogP ≤ 5 | 1.06 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122186716 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.